 NetScientific PLC LON:NSCI said its portfolio firm, PDS Biotechnology Corp NASDAQ:PDSB, it which it owns a 5.75 stake, has received US4.5mln from the net sale of tax benefits to an unrelated, profitable New Jersey corporation pursuant to the companys participation in the New Jersey Technology Business Tax Certificate Transfer Net Operating Loss NOL program for 2020. The NOL program enables qualified, unprofitable NJ-based technology or biotechnology companies with fewer than 225 U. 